Literature DB >> 34370861

Donor-CD4+ T Cells: A Trojan Horse for Human Herpes Virus-6 After Allogeneic Hematopoietic Cell Transplantation?

Yeon Joo Lee1,2, Yiqi Su1, Christina Cho3,2, Genovefa A Papanicolaou1,2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 34370861      PMCID： PMC8807176          DOI： 10.1093/infdis/jiab402

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   7.759


× No keyword cloud information.
  9 in total

1.  Human Herpesvirus 6 Reactivation Evaluated by Digital Polymerase Chain Reaction and Its Association With Dynamics of CD134-Positive T Cells After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Hitomi Nakayama; Rie Yamazaki; Jun Kato; Yuya Koda; Masatoshi Sakurai; Ryohei Abe; Shintaro Watanuki; Chieko Sumiya; Kohei Shiroshita; Shinya Fujita; Kentaro Yamaguchi; Shinichiro Okamoto; Takehiko Mori
Journal:  J Infect Dis       Date:  2019-08-09       Impact factor: 5.226

2.  Donor-Derived CD4+ T Cells and Human Herpesvirus 6B Detection After Allogeneic Hematopoietic Cell Transplantation.

Authors:  Derek J Hanson; Hu Xie; Danielle M Zerr; Wendy M Leisenring; Keith R Jerome; Meei-Li Huang; Terry Stevens-Ayers; Michael Boeckh; David M Koelle; Joshua A Hill
Journal:  J Infect Dis       Date:  2021-02-24       Impact factor: 5.226

3.  Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation.

Authors:  Danielle M Zerr; Lawrence Corey; Hyung W Kim; Meei-Li Huang; Long Nguy; Michael Boeckh
Journal:  Clin Infect Dis       Date:  2005-03-02       Impact factor: 9.079

4.  Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary?

Authors:  Brian C Betts; Jo-Anne H Young; Celalettin Ustun; Qing Cao; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2011-04-20       Impact factor: 5.742

5.  Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome.

Authors:  Raffaella Greco; Lara Crucitti; Maddalena Noviello; Sara Racca; Daniele Mannina; Alessandra Forcina; Francesca Lorentino; Veronica Valtolina; Serena Rolla; Roee Dvir; Mara Morelli; Fabio Giglio; Maria Chiara Barbanti; Maria Teresa Lupo Stanghellini; Chiara Oltolini; Luca Vago; Paolo Scarpellini; Andrea Assanelli; Matteo G Carrabba; Sarah Marktel; Massimo Bernardi; Consuelo Corti; Massimo Clementi; Jacopo Peccatori; Chiara Bonini; Fabio Ciceri
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-30       Impact factor: 5.742

Review 6.  Expanding Therapeutic Opportunities for Hematopoietic Stem Cell Transplantation: T Cell Depletion as a Model for the Targeted Allograft.

Authors:  Christina Cho; Miguel-Angel Perales
Journal:  Annu Rev Med       Date:  2018-10-25       Impact factor: 13.739

7.  Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.

Authors:  Amanda L Olson; Parastoo B Dahi; Junting Zheng; Sean M Devlin; Marissa Lubin; Anne Marie Gonzales; Sergio A Giralt; Miguel-Angel Perales; Esperanza B Papadopoulos; Doris M Ponce; James W Young; Nancy A Kernan; Andromachi Scaradavou; Richard J O'Reilly; Trudy N Small; Genovefa Papanicolaou; Juliet N Barker
Journal:  Biol Blood Marrow Transplant       Date:  2014-02-16       Impact factor: 5.742

8.  CD134 is a cellular receptor specific for human herpesvirus-6B entry.

Authors:  Huamin Tang; Satoshi Serada; Akiko Kawabata; Megumi Ota; Emi Hayashi; Tetsuji Naka; Koichi Yamanishi; Yasuko Mori
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-14       Impact factor: 11.205

9.  Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients.

Authors:  Wendi Zhou; Jeff Longmate; Simon F Lacey; Joycelynne M Palmer; Ghislaine Gallez-Hawkins; Lia Thao; Ricardo Spielberger; Ryotaro Nakamura; Stephen J Forman; John A Zaia; Don J Diamond
Journal:  Blood       Date:  2009-04-15       Impact factor: 22.113
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.